All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Biotech firm raises £40m for R&D

AIM-listed biotech firm e-Therapeutics placed £40m of new shares with institutional investors in a deal that will fund R&D spending over the next four years.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree